Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

Chronic diseases affect health and are long-lastinghealth condition that affects the quality of life. Itlimits the activity ...

I’ve been living with depression for almost 12 years. I’m 31 now and I found out I had major depressive disorder when I was 19. I had a miserable freshman year of college, but I didn't really ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

People with bipolar I disorder have had at least one manic episode preceded or followed by hypomanic or major depressive episodes. Bipolar II disorder is a separate diagnosis and is not a milder ...

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...

When you have major depressive disorder (MDD), understanding what to expect can help you manage the ups and downs. When someone I work with is newly diagnosed, I spend a lot of time educating them ...

A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...